Patients in Need
Today many disease states are treated with highly specialized medications. These fields have given us medical breakthroughs that have made significant impacts in the wellness of patients by creating specialty medications. Specialty medications are developed to treat the most complex, chronic, life threatening and rare disease states and are improving the effectiveness of treatment for multiple sclerosis, cancer, hepatitis, diabetes, HIV, and arthritis, among others and are restoring hope to the lives of patients. Specialty medications are expensive, and cost prohibitive for many patients, especially those on a fixed or low income, with limited or no prescription drug coverage.
Our Premium Assistance Funds
Our premium assistance program assists those who have health insurance but need help with the cost of their individual insurance premiums. The program is designed to assist patients that are diagnosed with Multiple Sclerosis (MS) who elect to pay out-of-pocket for private, independent or COBRA insurance coverage.
Funding Allocation Status
We currently have funding available for new Multiple Sclerosis Premium Assistance patients.
Multiple Sclerosis Premium Assistance Fund
Our Copay Funds
The Assistance Fund was established to assist patients who have insurance but cannot afford the co-pay for specialty medications. The Fund has established individual funds specific to certain disease states where the standard treatment involves the utilization of specialty medications.
Funding Allocation Status
We currently have funding available for new Idiopathic Parkinson’ s Disease copay patients and new Cystic Fibrosis copay patients. At this time, all available funding for all other disease states have been exhausted. Please check back frequently for updates.
Supported Therapies
|
|
|
|
|
